Categories

Six years ago, my doctor told me I had prostate cancer, and the news literally brought me to my knees. To…

Continue Reading

Our EVP of Human Resources Jayne Hart talks about why Myriad is such a special and unique place to work and…

Continue Reading

VP of Medical Services Susan Manley explains what genetic mutations are and how testing can definitively determine whether or not a…

Continue Reading

Dr. Johnathan Lancaster describes advances in the field of testing for hereditary endometrial and colon cancers, which are some of the…

Continue Reading

VP of Medical Services Susan Manley talks about the emphasis Myriad places on test accuracy and the steps we take to…

Continue Reading


CEO Mark Capone talks about the primary challenges facing the molecular diagnostics industry and Myriad’s role as an industry leader in…

Continue Reading

CEO Mark Capone describes Myriad’s efforts to ensure that patients have access to our tests because we understand how the tests…

Continue Reading

CEO Mark Capone explains what personalized medicine is and the role of genetics in tailoring and improving treatments for individual patients.…

Continue Reading

Myriad CEO Mark Capone notes that the current healthcare system in the U.S. is one of the most effective in the…

Continue Reading